Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002347477 | SCV002653330 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-03-21 | criteria provided, single submitter | clinical testing | The c.569_572dupCAGT pathogenic mutation, located in coding exon 6 of the PTEN gene, results from a duplication of CAGT at nucleotide position 569, causing a translational frameshift with a predicted alternate stop codon (p.A192Sfs*11). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |